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DOI: 10.1039/c0an00439aThe first probe for the fluorogenic determination of acetyl phosphate (AcP), (bpy)2Ru(1,10-
phenanthroline-5,6-dione dioxime) (RuPDO), was prepared and its reaction with AcP was studied in
detail. The emission of the weakly luminescent RuPDO is red shifted and strongly enhanced upon
reaction with AcP in the presence of metal cations like Zn2+ or Cu2+. The reaction occurs within 60 min
incubation time under highly biocompatible conditions (aqueous buffer of pH 7, 37 C). A linear
dynamic range from 10 to 200 mmol L1 is observed with an LOD of AcP of 3.4 mmol L1 (for RuPDO-
Zn). Other bio-phosphates studied show only weak interference. Furthermore, the applicability of the
probe in complex biological matrices was evaluated.Introduction
Acetyl phosphate (AcP) is a high energy metabolic compound
derived from acetic acid and orthophosphoric acid. It was first
found by Lipmann in the early forties of the last century1 leading
to the discovery of coenzyme A.2 Acetyl phosphate was also
proposed as a primeval form of metabolic energy currency due to
its simple chemical structure and high phosphorylation potential
(DG0 (AcP): 43 kJ mol1 and DG0 (ATP): 31 kJ mol1).3–5
Therefore, AcP is primarily found in prokaryotes to serve as
a regulatory signal transducer, i.e. in the ATP-dependent
proteolysis,6 activation of the phosphate regulation,7 in motility
and chemotaxis expression,8 or in the initiation of membrane
phospholipid synthesis9 of countless microorganisms. The steady
state concentration of AcP in wild type E. coli reaches at least 3
mmol L1(ref. 10) and Wolfe et al.11 proved that acetyl phosphate
acts as a global sign in E. coli. AcP is also a non-nucleotide
substrate for the Ca-ATPase12 and an important source for
regeneration of ATP.7 Recently, the presence of an acetate
kinase-phosphotransacylase-pathway (involving acetyl phos-
phate) was also validated for some eukaryotic microbe species.13
Up to date, there is no clear evidence that AcP is a stable
metabolic intermediate in higher living organisms. On the one
hand, enzymes permitting the production of acetyl phosphate
from citric acid for example are found in animal tissues.14 On the
other hand, also highly active acetylphosphatase is present in
these tissues.15 Furthermore, acetate—the prokaryotic metabolic
product of AcP breakdown—is generated endogenously inInstitute of Analytical Chemistry, Chemo- and Biosensors, University of
Regensburg, 93040 Regensburg, Germany. E-mail: axel.duerkop@
chemie.uni-r.de; Fax: +49 941 943 4064
† Electronic supplementary information (ESI) available: Effect of
Zn-concentration on luminescence intensity; testing of RuPDO in
different complex biological matrices. See DOI: 10.1039/c0an00439a
148 | Analyst, 2011, 136, 148–154mammalian cells from acetyl-CoA hydrolase without using
AcP.16 There might also be a chance of retrieving acetyl phos-
phate in those cells considering the Warburg hypothesis17 that
tumor cells generate their energy mainly by non-oxidative
breakdown of glucose followed by lactic acid fermentation. In
2009, this hypothesis could be confirmed with VA13 cells by
Engler et al.18 Further assuming that non-malign cells do not
produce and preserve AcP in high concentrations, it might be
a powerful tumor marker. AcP attracted some attention in the
commercial synthesis of ATP via acetate kinase. This system also
provides a cheap and stable source for regeneration of ATP in
bacterial batch reactors.19,20
Up to date, the most common methods for the determination of
acetyl phosphate are the colorimetric hydroxylaminolysis and
some acetate kinase (AcK) coupled enzymatic methods. The hy-
droxamate assay was originally developed by Lipmann and Tut-
tle21 and frequently optimized, among others, by Rose22 and
Pechere and Capony.23 Briefly, AcP is reacted with hydroxylamine
and the hydroxamic acid formed reacts with ferric ions to form an
orange colored complex. This assay is simple and fast but requires
strongly acidic pH and high concentrations of hydroxylamine (704
mM). This is not suitable for direct analysis of biological samples.
Its limit of detection (LOD) is about 40 mmol L1. Recently, this
assay was coupled to an enzymatic reaction overcoming some of
these limitations.24 AcP is hydrolyzed by lowly concentrated
hydroxylamine. The inorganic phosphate produced is then
determined with a commercially available kit25 using a purine
nucleoside phosphorylase to yield a product absorbing at 330 nm
at mmolar concentrations of AcP. The main drawback of this
assay is that the presence of high concentrations of inorganic
phosphate (Pi) in samples prevents direct AcP determination.
Further on, Pr€uß and Wolfe26 presented an AcK-based assay
wherein the ATP formed is determined by the Luciferase reac-
tion.27 This assay was further improved by Ito et al.28 andThis journal is ª The Royal Society of Chemistry 2011
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View Article OnlineZhao et al.29 Another sensitive, yet time consuming method
utilizing AcK involves the conversion of acetyl phosphate with
radioactive [3H]ADP to [3H]ATP, separation by thin layer chro-
matography (TLC) and scintillation signal readout.30 As low as
20 nmol L1 of AcP were determined. Furthermore, AcP was
assayed by supplementing cells with [32Pi] and 2D-TLC of the cell
extract.31 Most of these methods share the characteristics that
either they are conducted under non-biocompatible conditions or
that they are complicated and time consuming.
Our aim was to develop a luminescent method for the direct
determination of AcP under biocompatible conditions. We
intended to transfer the tunable (e.g. by the addition of Zn, Cu,
Ni, and Co) and selective reaction of hydroxylamines or
hydroxamic acids32,33 to a luminescent reporter molecule. Ruthe-
nium complexes are known to have interesting spectral properties,
e.g. large Stokes’ shift, high photostability and good quantum
yields. Hence, we found (bpy)2Ru(1,10-phenanthroline-5,6-dione
dioxime) (RuPDO) to be an interesting candidate for further
investigations. We show that upon reaction with AcP in the
presence of Zn2+ or Cu2+ a strong increase in luminescence
intensity is accompanied by a bathochromic shift. This selective
reaction occurs under highly biocompatible conditions and
enables determination of AcP down to the low mmol L1 range.
Although RuPDO does not emit from an excited singlet state, we
refer to it as a fluorogenic probe as this is a much more common
term than a luminogenic probe. Furthermore, we show the high
potential of RuPDO for determination of acetyl phosphate in
complex biological matrices.Experimental
Instrumentation
Absorption spectra were recorded on a Cary 50 Bio UV-Vis
Spectrophotometer (Varian, Australia, www.varianinc.com).
Luminescence spectra were recorded on an Aminco-Bowman AB
2 luminescence spectrometer (www.thermo.com) equipped with
a 150 W continuous wave xenon lamp as excitation light source.
All spectra are uncorrected. Lifetime measurements were done
on an ISS K2 multifrequency cross-correlation phase modula-
tion fluorimeter (www.iss.com) using an argon ion laser for
excitation. Microtiter plate experiments were performed on a
Tecan Genios Plus Reader (www.tecan.de) at lexc ¼ 485 nm and
lem ¼ 635 nm in black flat bottom 96 well plates from Greiner
Bio-One (www.gbo.com). pH was measured with a pH meter CG
842 from Schott (www.schott.com) at room temperature. The
ESI mass spectra were taken on a ThermoQuest TSQ 7000Scheme 1 Synthes
This journal is ª The Royal Society of Chemistry 2011(www.thermo.com) mass spectrometer. IR spectra of solids were
recorded with a diamond ATR-crystal on a Varian 670-IR
spectrometer (www.varianinc.com).
Materials
cis-Dichlorobis(2,20-bipyridine)ruthenium(II) dihydrate (Ru-
(bpy)2Cl2) was purchased from ABCR (www.abcr.de). All other
chemicals and solvents were purchased from Sigma Aldrich
(www.sigmaaldrich.com) or Acros Organics (www.acros.be).
Stock solutions of acetyl phosphate (10.0 or 1.0 mmol L1) were
prepared in HEPES buffer of pH 7.4 (40 mmol L1) shortly
before measurements. Stock solutions of RuPDO (1.0 mmol L1)
were prepared by pre-dissolving of 0.94 mg of the reagent in
10 mL of DMSO followed by dilution with HEPES buffer to
1.0 mL. The RuPDO stock solution was stored at 4 C. Stock
solutions of ZnCl2 were prepared by dissolving 34.1 mg of the
reagent in 50 mL of HEPES buffer.
Synthesis of RuPDO
RuPDO was synthesized with slight modifications according to
the literature procedure34,35 in good yields. Ru(bpy)2Cl2 (74 mg)
was dissolved in dry ethanol (10 mL), then 1,10-phenanthroline-
5,6-dione (phendione) (29 mg) was added and the violet solution
heated to reflux for 5 h under N2. After cooling to room
temperature, the solvent was removed via rotary evaporation.
Ru(bpy)2(phendione) was redissolved in ethanol (15 mL), CaCO3
(dried, 34 mg) added and the mixture was heated to 81 C. A
solution of NH2OH $HCl (53 mg) in 5 mL of ethanol was added
dropwise over a period of 1 h, while the orange solution turned to
a reddish color. After reflux for 5 h and cooling to room
temperature the solvent was evaporated. The remaining orange to
red colored solid was dissolved in a small amount of H2O and the
complex was precipitated by adding excess of NH4PF6 (Scheme 1).
The red precipitate was washed with few mL of water and diethyl
ether. The crude product (60% yield) was recrystallized from
acetone (50% yield). Found: C 38.85, H 3.21, N 11.51.
C32H24F12N8O2P2Ru$3H2O requires C 38.53, H 3.03, N 11.23%;
m/z (ESI) 326.8 (M2+, C32H24N8O2Ru requires 327.1).
Protocol for determination of AcP
50 mL of the RuPDO stock solution (final concentration 50 mmol
L1 in 40 mmol L1 HEPES buffer of pH 7.4) and 100 mL of
ZnCl2 (final concentration 0.5 mmol L
1) were added to HEPES
buffer of pH 7.4 (40 mmol L1) containing at least 0.05 mmol L1
of AcP and made up to 1 mL (for tests in cuvettes). One-tenth ofis of RuPDO.
Analyst, 2011, 136, 148–154 | 149
Fig. 1 Excitation spectrum of RuPDO-Zn and emission spectra of
RuPDO-Zn and the reaction product with AcP (AcP-RuPDO-Zn) after
addition of increasing concentrations of AcP: 50 mmol L1 RuPDO, 0.5
mmol L1 Zn2+, 20 mmol L1, 0.1 mmol L1, 0.5 mmol L1 of AcP,
respectively, 40 mmol L1 HEPES buffer of pH 7.4, 60 min incubation at
37 C. The emission spectrum of RuPDO closely matches the one of
RuPDO-Zn and is almost invisible.
Table 1 Spectral properties of RuPDO and the reaction product (AcP-
RuPDO-Zn)
RuPDO AcP-RuPDO-Zn
lexc/nm 469 469
lem/nm 610 640
3430, 3469/
L mol1 cm1
7200, 5800 6300, 4400
Fa 0.64% 4.5%
sb s1: 351 ns (81.6%) s1: 280 ns (19.6%)
s2: 81 ns (16.3%)
(c2 ¼ 2.5)
s2: 149 ns (80.4%)
(c2 ¼ 2.1)
a In air saturated ethanol; reference: Rhodamine 6G (F ¼ 0.95). b In air
saturated HEPES buffer (40 mmol L1, pH 7.4).
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View Article Onlineall volumes were used for microtiter plate based experiments
(final volume 0.1 mL). The same amount of RuPDO and ZnCl2
was added to the control containing no AcP. The reaction
vials were then kept at 37 C for 60 min before measuring
luminescence.Results and discussion
Spectral properties and response to AcP
A solution of RuPDO in aqueous buffer shows only weak
luminescence (lexc/em at 469/610 nm). For determination of
acetyl phosphate, the vic-oxime groups of the phenanthroline
ligand are activated in situ by the addition of cations like Zn2+,
Cu2+ or Ni2+. The addition of these activators does not alter the
emission spectrum of RuPDO. The luminescence spectra of
RuPDO with (RuPDO-Zn) and without activator cation
(RuPDO) and in the presence of AcP (AcP-RuPDO-Zn) are
shown in Fig. 1.
A red shift of the emission of RuPDO of 30 nm (from 610 nm
to 640 nm) is observed in the presence of AcP. This is also150 | Analyst, 2011, 136, 148–154accompanied by a strong enhancement of fluorescence intensity,
increase of quantum yield and change of decay time (see Table 1).
The wavelength of the excitation maximum remains unchanged.
These spectroscopic changes solely occur in the presence of
transition metal cations and active acetic acid esters like AcP or
4-nitrophenyl acetate (4 NA). This effect is not observed in the
presence of Ca2+ or Mg2+ (data not shown). Hence, a proposed
reaction mechanism is shown in Scheme 2 and evidence for the
mechanism is given in a later section.
A further benefit of RuPDO is the large Stokes’ shift of 141 nm
(RuPDO-Zn) and 171 nm (AcP-RuPDO-Zn), respectively. This
warrants excellent blocking of excitation light in filter-based
fluorescence instrumentation. The fairly strong red fluorescence
of AcP-RuPDO-Zn also permits measurements in biological
samples with almost zero background. Furthermore, the reaction
product can easily be distinguished from the probe itself as the
former shows much stronger and red shifted (by 30 nm)
emission.
The longwave emission of AcP-RuPDO-Zn suggests further
investigations for detection of AcP in vivo, where emission at
>600 nm is a prerequisite to avoid autofluorescence from tissue
and warrants suitable penetration depth (due to reduced
absorption of tissue).
Choice of activating cation
Several cations were screened for their oxime activation prop-
erties (Table 2). The reaction of RuPDO with AcP was carried
out in HEPES buffer, pH 7.4 (40 mmol L1), at 37 C in the
presence of 1 mmol L1 of AcP, 0.5 mmol L1 of activating cation
and 50 mmol L1 of RuPDO. The luminescence intensity at 640
nm was referenced with respect to the signal found for Zn2+-
activation at 640 nm after 60 min incubation time. Finally, only
Zn2+ and Cu2+ were selected for further investigations due to their
higher biocompatibility compared to the other cations tested and
the strong response to AcP.
Effect of pH and reaction time
The effect of pH on the reaction of Zn2+- and Cu2+-activated
RuPDO with AcP was investigated via luminescence
measurement at 640 nm. The pH dependence of the reaction
of RuPDO-Zn and RuPDO-Cu with AcP is shown in Fig. 2. It
is in good correlation to previous data of Cu2+ and Zn2+
activated oximes.36,37 It is possible to determine AcP at phys-
iological pH with RuPDO-Zn as well as with RuPDO-Cu.
Therefore, pH 7.4 was chosen as the optimal pH for all further
investigations.
The reaction rate of 50 mmol L1 RuPDO in the presence of 0.5
mmol L1 Zn2+ or Cu2+ with 0.1, 0.2 and 1 mmol L1 of AcP,
respectively, was also examined at 37 C via F/F0 at 640 nm
(Fig. 3). After 60 min incubation, over 90% of the maximum
signal is achieved at all concentrations of AcP. Therefore, a 1 h
incubation time was chosen for all further investigations.
Mechanism of fluorogenic reaction
We were further interested in the mechanism of the reaction
between RuPDO-Zn and AcP. The proposed reaction mecha-
nism (Scheme 2) was inspired by the works of Lipmann andThis journal is ª The Royal Society of Chemistry 2011
Table 2 Effect of activating cations
Activator cation IM
x+/IZn
2+a Activator cation IM
x+/IZn2+
a
Zn2+ 100% Ce4+ 17%
Cu+ 52% Ce3+ 66%
Cu2+ 87% La3+ 39%
Cd2+ 51% Ni2+ 86%
Pd2+ 13% Yb3+ 54%
Ru3+ 13% Y3+ 58%
Cr2+ 13% Tb3+ 53%
Ag+ 18% Eu3+ 46%
Co2+ 14%
a After 60 min incubation time, each.
Fig. 2 Effect of pH on the reaction of RuPDO-Zn/Cu with AcP. 10
mmol L1 piperacine–glycylglycine buffer, 50 mmol L1 RuPDO, 0.5
mmol L1 ZnCl2 or CuCl2, respectively, 1 mmol L
1 AcP, 60 min incu-
bation at 37 C (n ¼ 4).
Fig. 3 Effect of reaction time on the reaction of RuPDO-Zn with AcP.
40 mmol L1 HEPES buffer of pH 7.4, 50 mmol L1 RuPDO, 0.5 mmol
L1 Zn2+, 0.1, 0.2, and 1 mmol L1 of AcP, respectively, 60 min reaction at
37 C (n ¼ 4).
Scheme 2 Reaction mechanism of RuPDO-Zn with AcP.
This journal is ª The Royal Society of Chemistry 2011
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View Article OnlineTuttle,21 Weijnen et al.38 and Mancin et al.39 The two main
possibilities clearly are either an acetylation of the oxime groups
or a phosphorylation. Therefore, we added 4-nitrophenyl acetate
(4 NA) to a buffered solution of RuPDO-Zn and in another
experiment bis(nitrophenyl) phosphate (BNPP). In case of 1
mmol L1 4 NA, the same increase of luminescence intensityAnalyst, 2011, 136, 148–154 | 151
Fig. 4 Normalized fluorescence at 640 nm vs. mole fraction AcP. Data
collected after 60 min of incubation at 37 C in 40 mmol L1 HEPES of
pH 7.4 (n ¼ 4).
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View Article Onlinepeaking at 640 nm was observed as with AcP solution of equal
concentration. Additionally, an increase of the absorbance at 400
nm was found due to absorption of the 4-nitrophenolate anion
formed during the reaction. Neither the emission spectrum nor
the absorption spectrum was affected during reaction of
RuPDO-Zn with BNPP or other biologically relevant phos-
phates like inorganic phosphate (Pi), pyrophosphate (PP), ATP
and ADP. This is a clear evidence for the oxime acetylation
thesis. Furthermore, the IR spectra of RuPDO prior and after
reaction with AcP (AcP-RuPDO-Zn) differ mainly due to the
appearance of the new aliphatic C–H stretching vibrations at
2923 and 2853 cm1, respectively, of the O–Ac group (AcP-
RuPDO-Zn).Complex stoichiometry and calibration plots
The stoichiometry of the reaction was determined via
Job’s method of continuous variation. From Fig. 4, a 1 : 1Fig. 5 Plot of F/F0 vs. [AcP] collected after 60 min of incubation at 37
C
in 40 mmol L1 HEPES of pH 7.4 (n ¼ 4).
152 | Analyst, 2011, 136, 148–154stoichiometry of the reaction of RuPDO-Zn and AcP under the
given reaction conditions can be deduced. However, one can
assume that in the presence of excess acetyl phosphate both
oxime groups of RuPDO will be involved in the reaction. This
behavior was observed in the calibration plots in Fig. 5. The fact
that linearity of the calibration plot exceeds equimolar concen-
trations between AcP and RuPDO suggests the participation of
the second oxime reaction site. A linear dynamic range from 10
to 200 mmol L1 of AcP and 80 to 400 mmol L1 of AcP at a probe
concentration of 50 mmol L1 is observed for RuPDO-Zn and
RuPDO-Cu, respectively. The regression equation for RuPDO-
Zn is F/F0 ¼ 16.59 L mmol1 [AcP] + 1.29 (r ¼ 0.990) and F/F0 ¼
4.28 L mmol1 [AcP] + 0.74 (r¼ 0.990) for RuPDO-Cu. The limit
of detection of AcP via RuPDO-Zn is 3.4 mmol L1. Hence, AcP
can be determined at least at 10 times lower concentrations
compared to the method of Lipmann and Tuttle.21Interference of other relevant phosphates
The reaction of RuPDO-Zn with AcP in the presence of equi-
molar concentrations of inorganic phosphate (Pi), pyrophos-
phate (PP) and ATP was monitored using luminescence (Fig. 6).
These phosphates slightly quench the luminescence of RuPDO-
Zn, probably due to coordination to Zn2+. Within a tolerance
limit of 10% the following concentrations of interferents are
acceptable: Pi ¼ 1 mmol L1, PP ¼ 0.22 mmol L1 and ATP ¼
0.67 mmol L1. Hence, even in the presence of equimolar
concentrations of AcP and phosphate (1 mmol L1 as found in
DMEM medium, see next section) a pronounced increase of
luminescence is detectable. As a result, the slope of a calibration
plot for AcP in the presence of equimolar phosphate is slightly
reduced. We assume that binding of these phosphates to
RuPDO-Zn blocks the ‘‘binding-site’’ for AcP, resulting in
a lower acetylation-rate and therefore a lower luminescence.
Addition of phosphate to a reacted solution (90 min) of AcP-
RuPDO-Zn does not change the signal (data not shown),
substantiating the binding-site-blocking thesis. The binding of
phosphates to the probe can adequately be reduced by adding
a higher amount of Zn2+ to the sample, resulting in higher
luminescence intensity due to complexation of phosphate by freeFig. 6 Effect of bio-phosphates on the luminescence of the reaction of
RuPDO-Zn with AcP. 40 mmol L1 HEPES buffer of pH 7.4, 50 mmol
L1 RuPDO, 0.5 mmol L1 Zn2+, 1 mmol L1 of AcP and inorganic
phosphate (Pi), pyrophosphate (PP), ATP, each, 60 min reaction at 37 C
(n ¼ 4).
This journal is ª The Royal Society of Chemistry 2011
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View Article OnlineZn2+ in solution (Fig. S1†). It is obvious from Fig. S1† that
higher concentrations of Zn2+ are able to overcome the
quenching-effect of Pi.Tests of RuPDO-Zn in cell medium containing NRK cells
The reaction of RuPDO-Zn with AcP was examined in Dul-
becco’s Modified Eagle Medium (DMEM) and also in DMEM
medium containing normal rat kidney (NRK) cells in order to
test the future applicability of the probe for measurements in
biological matrices. DMEM medium used in the experiments
contains, among others, high millimolar concentrations of
inorganic compounds like CaCl2, NaH2PO4 and KCl, various
amounts of different amino acids and 10% (w/w) fetal calf serum.
NRK cells were grown in DMEM medium for 2 days. During
this period the medium is further enriched with products of cell
metabolism. Hence, the cell medium used is a complex matrix
and served as reaction medium without further workup. The
medium together with 50 mmol L1 of RuPDO, 0.5 mmol L1
ZnCl2 and various amounts of AcP was incubated at 37
C and
the progress of the reaction was monitored for 90 min by
recording the increase of the luminescence intensity at 640 nm.
An almost 2.5 fold signal increase in both DMEM medium
containing NRK cells (Fig. 7) and medium without cells (data
not shown) was observed on addition of 2 mmol L1 of AcP. As
a matter of fact, the signal increase is not as high as observed in
plain aqueous buffered solution due to the complex matrix. The
slope is reduced by a factor of 20 compared to aqueous buffer.
However, it is obvious from the calibration plot that determi-
nation of AcP from 0.5 to 2 mmol L1 is possible with reasonable
precision in complex biological matrices using the luminescence
of RuPDO-Zn. Importantly, the reaction time in cell medium is
much shorter compared to the reaction in aqueous buffer. The
maximum luminescence intensity at 640 nm is obtained afterFig. 7 Luminescence of RuPDO-Zn in suspensions of NRK cells in
DMEM cell medium after spiking with AcP. Solid lines (I and II)
represent unspiked samples without cells (I) and in the presence of cells
(II). Dashed lines (III to VI) represent spiked samples of cell media
containing NRK cells. AcP concentration is increasing from 0.5 mmol
L1 (III) to 2 mmol L1 (VI) (n ¼ 4).
This journal is ª The Royal Society of Chemistry 201130 min of incubation. This strongly supports the proposed
reaction mechanism of RuPDO-Zn. A high amount of RuPDO-
Zn is already blocked in the presence of high concentrations of
phosphate. Therefore, only few RuPDO-Zn molecules are able to
react with AcP, resulting in an decreased luminescence intensity
at 640 nm and shorter reaction time compared to a sample in
plain buffer.
Additional tests of RuPDO-Zn were conducted in E. coli
lysogeny broth (LB) media without bacteria, in LB media con-
taining E. coli, and in LB media containing sonicated E. coli (see
ESI†). The kinetic of the reaction of RuPDO-Zn with AcP in
E. coli LB media without bacteria is shown in Fig. S2†. The
reaction of RuPDO-Zn with AcP is slower than in DMEM
medium (Fig. 7). While the increase of luminescence intensity is
slower, the slope of the calibration plot is steeper (Fig. S3†) than
in DMEM medium (inset of Fig. 7). The kinetic of the reaction of
RuPDO-Zn with AcP in LB media containing E. coli is shown in
Fig. S4† and remains almost unchanged with respect to LB
medium without E. coli (Fig. S2†). The increase of luminescence
intensity is lower, resulting in a lower slope of the calibration plot
(Fig. S5†) than in LB medium without E. coli (Fig. S3†). This
behavior could be expected because cells usually show strong
scatter in luminescence measurements. The kinetic of the reac-
tion of RuPDO-Zn with AcP in LB media containing sonicated
E. coli is shown in Fig. S6† and remains almost unchanged with
respect to LB medium containing E. coli (Fig. S4†). Here, the
increase of luminescence intensity (Fig. S7†) is almost constant
with respect to the unlysed cells (Fig. S5†). These data clearly
show the applicability of the probe in various complex biological
matrices.
Conclusions
The first fluorogenic probe RuPDO is introduced for the rapid and
direct determination of acetyl phosphate in aqueous solutions at
neutral pH. Unlike in common methods for determination of AcP,
the presence of millimolar inorganic phosphate only weakly
reduces sensitivity and no radioactive waste is produced.
Successful determination of AcP in complex biological matrices
and the longwave emission of AcP-RuPDO-Zn suggest further
investigations for detection of AcP in vivo. A combination of
RuPDO with suitable enzymes involved in the formation or
conversion of AcP suggests luminescent probing of other biolog-
ical important analytes like glucose, a-ketoglutarate, and acetate.
These experiments are now under way.
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